Sign In
Buy MMC
$182.70
+0 (+0%)
At Close: Apr 10, 2026
Can Marsh & McLennan (MMC) Sustain Its Beat Streak in Q4 Earnings?
11:17am, Tuesday, 24'th Jan 2023
Marsh & McLennan's (MMC) fourth-quarter results are likely to reflect solid segmental performances, partly offset by elevated compensation and benefits expenses.
The Zacks Analyst Blog Highlights Exxon Mobil, Fomento Economico Mexicano, Prologis, Marsh & McLennan and Becton Dickinson
03:05pm, Monday, 23'rd Jan 2023 Zacks Investment Research
Exxon Mobil, Fomento Economico Mexicano, Prologis, Marsh & McLennan and Becton Dickinson are part of the Zacks top Analyst Blog.
What's in Store for Arthur J. Gallagher (AJG) in Q4 Earnings?
11:31am, Monday, 23'rd Jan 2023 Zacks Investment Research
Arthur J. Gallagher's (AJG) fourth-quarter results are expected to reflect new business, strong retention and renewal premium increases across its business lines.
Top Stock Reports for Exxon Mobil, Fomento Economico Mexicano & Prologis
09:47pm, Friday, 20'th Jan 2023 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), Fomento Econmico Mexicano, S.A.B. de C.V. (FMX) and Prologis, Inc. (PLD).
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2023
03:00pm, Friday, 20'th Jan 2023 Benzinga
Upgrades
For Par Pacific Holdings Inc (NYSE:PARR), Piper Sandler upgraded the previous rating of Neutral to Overweight. In the third quarter, Par Pacific Hldgs showed an EPS of $2.88, compared to $0.7
5 Insurance Stocks Likely to Zoom Past Q4 Earnings Estimates
01:40pm, Friday, 20'th Jan 2023 Zacks Investment Research
Increasing interest rates, growing awareness, the scaling of businesses and other factors are likely to have supported the fourth-quarter performances of insurers like Marsh & McLennan, American Inter
Why Marsh & McLennan (MMC) is Poised to Beat Earnings Estimates Again
05:10pm, Thursday, 19'th Jan 2023 Zacks Investment Research
Marsh & McLennan (MMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Marsh & McLennan (MMC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
03:01pm, Thursday, 19'th Jan 2023 Zacks Investment Research
Marsh & McLennan (MMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Marsh & McLennan (MMC) is Poised to Beat Earnings Estimates Again
01:32pm, Thursday, 19'th Jan 2023
Marsh & McLennan (MMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Arthur J. Gallagher (AJG) Expands in Ireland With Buyout
03:41pm, Wednesday, 18'th Jan 2023 Zacks Investment Research
The buyout of First Ireland Risk will help Arthur J. Gallagher & Co.'s (AJG) expand its footprint in Ireland.
The Zacks Analyst Blog Highlights Aflac, Reinsurance Group of America, Marsh & McLennan Companies, Unum Group and The Travelers Companies
12:55pm, Tuesday, 17'th Jan 2023 Zacks Investment Research
Aflac, Reinsurance Group of America, Marsh & McLennan Companies, Unum Group and The Travelers Companies are part of the Zacks top analyst blog.
5 Insurance Stocks to Buy Ahead of Q4 Earnings Results
12:29pm, Monday, 16'th Jan 2023 Zacks Investment Research
Five insurance companies are set to beat on fourth-quarter earnings. These are: AFL, RGA, MMC, UNM and TRV.
Arthur J. Gallagher (AJG) Aids Health Insurance Market With JCB
01:38pm, Thursday, 12'th Jan 2023 Zacks Investment Research
Arthur J. Gallagher's (AJG) acquisition of JCB is likely to strengthen its student health insurance market expertise and fortify its presence on the West Coast.
Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023
03:01pm, Monday, 09'th Jan 2023 Benzinga
Upgrades
For Helmerich & Payne Inc (NYSE:HP), B of A Securities upgraded the previous rating of Neutral to Buy. For the fourth quarter, Helmerich & Payne had an EPS of $0.45, compared to year-ago quar
Adobe To Rally 25%? Here Are 10 Other Analyst Forecasts For Monday
01:23pm, Monday, 09'th Jan 2023 Benzinga
Piper Sandler cut Salesforce, Inc. (NYSE: CRM) price target from $175 to $171. Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. Salesforce shares rose 0.6% to $14
